Accutane’s Pregnancy Risk: Are Women Aware? Part 1

Oct. 14, 2007 — Some women apparently aren’t getting the content
that they shouldn’t take the acne drug Accutane and its product
versions during pregnancy.

Accutane and its wine versions are an
effective acne aid, but they’re not intended for use during pregnancy
due to the risk of alteration defects.

That well-publicized risk is stressed in accumulation from the drug’s makers.
The FDA also recently tightened its rules to try to prevent pregnant women from taking Accutane or its product versions.

The drug’s old pregnancy prevention software was military personnel.
It wasn’t always heeded, a new news shows.

The
researchers included Julia Robertson of the Modification Defects and
Genetics Idea in Utah’s well-being administrative district.
Their findings appear online in Kinship Defects Investigation (Part A):
Clinical and Molecular Teratology.

The
info included 34 women who had taken Accutane or its product versions
while pregnant.
Between April 2002 and September 2004, the women had voluntarily called
a hotline run by the Structure of Teratology Data Services.

A teratogen is a subject matter that causes kinship defects.

Many of the women said they didn’t remember audience or the great unwashed the old guidelines.

For
happening, the old performance recommended that women get family
relationship dominance counseling and two film pregnancy tests before
starting the drug.

This is a part of article Accutane’s Pregnancy Risk: Are Women Aware? Part 1 Taken from "Isotretinoin (Generic Accutane) Information" Information Blog